Agent for treatment of Parkinson's disease

Details Agent for treatment of Parkinson's disease Agent for treatment of Parkinson's disease

1989-03-01

1990-11-13

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

424 941, 424 944, A61K 31455, A61K 3170, C07H 19207

Patent

active

049702009

ABSTRACT:
The enzyme cofactor nicotinamide adenine dinucleotide or a salt thereof is useful for the treatment of Parkinson's disease.

REFERENCES:
patent: 3326756 (1967-06-01), O'Hollaren
patent: 3341412 (1967-09-01), O'Hollaren et al.
Birkmayer, W. J., Neuro-Visceral Relations, vol. 31, suppl. IX, pp. 297-308 (1969).
Birkmayer, W., et al., Archiv fur Psychiatrie und Zeitschrift F. D. Ges. Neurologie, vol. 210, No. 1, pp. 29-35 (1967).
Ramsey, R., et al., BBRC, vol. 135, No. 1, 26, pp. 269-275 (1986).
Blair, J. et al., The Lancet 1 (8369), p. 167 (1984).
Grisham, M. et al., J. Neurochem. 49, No. 1, pp. 876-882 (1987).
Singer, T. P. et al., J. Neurochem., vol. 49, No. 1, pp. 1-8 (1987).
Birkmayer, W., et al., Ann. Clin. Lab. Sci., vol. 19, No. 1, pp. 38-43 (1989).

Affiliated with

Also associated with

Rating

Agent for treatment of Parkinson's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for treatment of Parkinson's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treatment of Parkinson's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-776960